Amidst pandemic science works across borders but governments revert back to national protectiveness-a recent example from Germany is tightening oversight on foreign investments. This will hurt GER #biotech as international investments r critical 4 success in our industry #COVID19

So thrilled to have joined Trophic Communications to support EU #LifeScience companies in their aim to gain visibility and exposure in the EU and US #media- and #investment community! Learn more about what we do, and meet my new colleagues here: trophic.eu

#Congratulations to my Trophic Communications colleagues Joanne Tudorica, Marie-Theresa Weickert and @vw_fisher!

#Eindhoven-based @GtxMedical is developing Go-2 Targeted Epidural Spinal Stimulation (#TESS) therapy and announced today that they received #FDA #BreakthroughDeviceDesignation - Congratulations! businesswire.com/news/home/2020…

Congrats to Trophic's LuisKramer, Gefeliciteerd met je verjaardag Luis! 🎂🍻

Dutch biotech AM-Pharma today announced the enrollment of the 1st pt in their Ph.III #REVIVAL study for patients with #sepsis-assoc. #AcuteKidneyInjury, affecting millions of people every year: youtu.be/vUci0vNPv6Y bit.ly/3pgeJro

Congratulations to the Trophic Communications team, 3 years and many more to come!

Happy 3rd birthday Trophic Communications 🥳 very happy to be part of this team!

We’re hiring!

A novel, differentiating approach by #DiosCURE to prevent and treat #COVID19, with the potential to avoid the emergence of escape mutants, published in Science Magazine. Learn more about DiosCURE here: dioscure.com science.sciencemag.org/content/early/… #SARSCoV2

While 2020 was certainly a challenging year, it has also been a productive one for us at Trophic. We look forward to more exciting #LifeScience #communication projects & growing our team further in 2021! #YearInReview